UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 170 filers reported holding UNIQURE NV in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,241,088 | -60.5% | 632,055 | -32.5% | 0.00% | -100.0% |
| Q2 2023 | $10,726,583 | +112.8% | 936,002 | +274.0% | 0.00% | – |
| Q1 2023 | $5,040,559 | -61.0% | 250,276 | -56.1% | 0.00% | -100.0% |
| Q4 2022 | $12,913,263 | +10.1% | 569,619 | -8.9% | 0.00% | 0.0% |
| Q3 2022 | $11,730,000 | -2.5% | 625,250 | -3.1% | 0.00% | 0.0% |
| Q2 2022 | $12,032,000 | +21.1% | 645,501 | +17.4% | 0.00% | +50.0% |
| Q1 2022 | $9,938,000 | -50.6% | 549,958 | -43.3% | 0.00% | – |
| Q4 2021 | $20,118,000 | +41.9% | 969,982 | +119.0% | 0.00% | -100.0% |
| Q3 2021 | $14,174,000 | -17.1% | 442,832 | -20.2% | 0.00% | 0.0% |
| Q2 2021 | $17,094,000 | +54.6% | 555,007 | +69.1% | 0.00% | +200.0% |
| Q1 2021 | $11,059,000 | -60.4% | 328,241 | -57.5% | 0.00% | -50.0% |
| Q4 2020 | $27,910,000 | -7.8% | 772,538 | -6.0% | 0.00% | -66.7% |
| Q3 2020 | $30,263,000 | -43.2% | 821,710 | -30.5% | 0.01% | -53.8% |
| Q2 2020 | $53,289,000 | +106.9% | 1,182,604 | +117.8% | 0.01% | +62.5% |
| Q1 2020 | $25,761,000 | -45.2% | 542,900 | -17.2% | 0.01% | -38.5% |
| Q4 2019 | $46,997,000 | +71.2% | 655,827 | -5.9% | 0.01% | +30.0% |
| Q3 2019 | $27,445,000 | -90.3% | 697,300 | -80.7% | 0.01% | -71.4% |
| Q2 2019 | $282,697,000 | +505.2% | 3,617,350 | +362.0% | 0.04% | +84.2% |
| Q1 2019 | $46,709,000 | +1166.2% | 783,057 | +511.8% | 0.02% | +1800.0% |
| Q4 2018 | $3,689,000 | -47.7% | 128,000 | -33.9% | 0.00% | -50.0% |
| Q3 2018 | $7,049,000 | -55.5% | 193,695 | -53.8% | 0.00% | -66.7% |
| Q2 2018 | $15,858,000 | +29.5% | 419,529 | -19.5% | 0.01% | +50.0% |
| Q1 2018 | $12,250,000 | +45.4% | 521,250 | +21.2% | 0.00% | +33.3% |
| Q4 2017 | $8,425,000 | +10301.2% | 430,032 | +3981.9% | 0.00% | – |
| Q3 2016 | $81,000 | -74.8% | 10,535 | -75.8% | 0.00% | – |
| Q2 2016 | $321,000 | -12.5% | 43,484 | +40.7% | 0.00% | – |
| Q1 2016 | $367,000 | -90.8% | 30,900 | -87.2% | 0.00% | -100.0% |
| Q4 2015 | $4,001,000 | +77.2% | 241,900 | +119.1% | 0.00% | – |
| Q3 2015 | $2,258,000 | +57.5% | 110,397 | +107.9% | 0.00% | – |
| Q2 2015 | $1,434,000 | – | 53,104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,241,500 | $8,330,465 | 2.81% |
| Nantahala Capital Management | 3,023,799 | $20,289,691 | 1.73% |
| AlphaCentric Advisors LLC | 391,500 | $2,626,965 | 1.49% |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO | 828,201 | $414,741 | 1.06% |
| TANG CAPITAL MANAGEMENT LLC | 935,800 | $6,279,218 | 0.89% |
| 683 Capital Management, LLC | 1,575,000 | $10,568,250 | 0.82% |
| Privium Fund Management B.V. | 281,606 | $1,889,576 | 0.56% |
| SANDERS MORRIS HARRIS LLC | 368,095 | $2,313,592 | 0.48% |
| Ghost Tree Capital, LLC | 215,000 | $1,442,650 | 0.47% |
| Sonic GP LLC | 50,000 | $335,500 | 0.33% |